CBD anxiety trial for brain cancer patients ends early
Symptom relief
Terminated
This study aimed to see if a high-CBD hemp product could reduce anxiety and improve quality of life in people newly diagnosed with glioblastoma, a serious brain tumor. The trial planned to compare the CBD product to a placebo over 8 weeks, but it was stopped early after only 2 pe…
Phase: PHASE2 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC